(DNOW) Now - Overview
Stock: Pipes, Valves, Fittings, Pumps, Automation
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 37.0% |
| Relative Tail Risk | -2.70% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.48 |
| Alpha | -3.67 |
| Character TTM | |
|---|---|
| Beta | 1.103 |
| Beta Downside | 1.243 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.36% |
| CAGR/Max DD | 0.14 |
Description: DNOW Now January 15, 2026
DNOW Inc. (NYSE:DNOW) is a global distributor of downstream energy and industrial products, serving the petroleum refining, chemical processing, LNG, power generation, and gas utility markets across North America, Europe, Asia-Pacific, and the Middle East. Its catalog spans pipes, valves, fittings, gaskets, instrumentation, pumping solutions, modular process equipment, consumables, artificial-lift systems, OEM gear (e.g., pumps, compressors, generator sets), and a suite of supply-chain services such as inventory planning, procurement, logistics, and performance-metrics reporting. The company supports upstream, midstream, and downstream customers-including drilling contractors, oil & gas producers, refineries, petrochemical plants, utilities, and industrial manufacturers-and operates under the DNOW brand after rebranding from NOW Inc. in January 2024.
Key metrics that analysts watch: DNOW reported FY 2023 revenue of approximately $5.9 billion, with an adjusted EBITDA margin of ~9.5%, reflecting steady demand for infrastructure-related components amid rising global LNG capacity additions. The sector’s growth is driven by higher capital-expenditure cycles in the U.S. Energy Transition (e.g., renewable natural gas and hydrogen retrofits) and continued upstream drilling activity in the Permian Basin. Additionally, DNOW’s inventory-management platform has been cited for improving order-fill rates by 4-5 percentage points, a competitive edge in a market where supply-chain disruptions remain a material risk. For a deeper quantitative view, consider exploring ValueRay’s DNOW dashboard to see how these drivers translate into valuation scenarios.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 95.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA -6.54 > 1.0 |
| NWC/Revenue: 27.18% < 20% (prev 27.20%; Δ -0.02% < -1%) |
| CFO/TA 0.12 > 3% & CFO 194.0m > Net Income 95.0m |
| Net Debt (-228.0m) to EBITDA (166.0m): -1.37 < 3 |
| Current Ratio: 2.52 > 1.5 & < 3 |
| Outstanding Shares: last quarter (106.0m) vs 12m ago -0.94% < -2% |
| Gross Margin: 23.07% > 18% (prev 0.23%; Δ 2284 % > 0.5%) |
| Asset Turnover: 149.8% > 50% (prev 148.5%; Δ 1.28% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBITDA TTM and Interest Expense TTM) |
Altman Z'' -0.01
| A: 0.40 (Total Current Assets 1.10b - Total Current Liabilities 435.0m) / Total Assets 1.66b |
| B: -0.41 (Retained Earnings -675.0m / Total Assets 1.66b) |
| C: 0.08 (EBIT TTM 124.0m / Avg Total Assets 1.62b) |
| D: -1.72 (Book Value of Equity -819.0m / Total Liabilities 475.0m) |
| Altman-Z'' Score: -0.01 = B |
Beneish M -3.05
| DSRI: 1.03 (Receivables 429.0m/405.0m, Revenue 2.43b/2.36b) |
| GMI: 0.99 (GM 23.07% / 22.74%) |
| AQI: 1.01 (AQ_t 0.25 / AQ_t-1 0.25) |
| SGI: 1.03 (Revenue 2.43b / 2.36b) |
| TATA: -0.06 (NI 95.0m - CFO 194.0m) / TA 1.66b) |
| Beneish M-Score: -3.05 (Cap -4..+1) = AA |
What is the price of DNOW shares?
Over the past week, the price has changed by +10.34%, over one month by +23.51%, over three months by +23.51% and over the past year by +17.20%.
Is DNOW a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the DNOW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 17 | 1.4% |
| Analysts Target Price | 17 | 1.4% |
| ValueRay Target Price | 17.1 | 1.8% |
DNOW Fundamental Data Overview February 03, 2026
P/E Forward = 35.9712
P/S = 1.1596
P/B = 2.3671
Revenue TTM = 2.43b USD
EBIT TTM = 124.0m USD
EBITDA TTM = 166.0m USD
Long Term Debt = 38.0m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 13.0m USD (from shortTermDebt, last quarter)
Debt = 38.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -228.0m USD (from netDebt column, last quarter)
Enterprise Value = 2.59b USD (2.82b + Debt 38.0m - CCE 266.0m)
Interest Coverage Ratio = unknown (Ebit TTM 124.0m / Interest Expense TTM 0.0)
EV/FCF = 14.65x (Enterprise Value 2.59b / FCF TTM 177.0m)
FCF Yield = 6.83% (FCF TTM 177.0m / Enterprise Value 2.59b)
FCF Margin = 7.28% (FCF TTM 177.0m / Revenue TTM 2.43b)
Net Margin = 3.91% (Net Income TTM 95.0m / Revenue TTM 2.43b)
Gross Margin = 23.07% ((Revenue TTM 2.43b - Cost of Revenue TTM 1.87b) / Revenue TTM)
Gross Margin QoQ = 22.87% (prev 22.93%)
Tobins Q-Ratio = 1.56 (Enterprise Value 2.59b / Total Assets 1.66b)
Interest Expense / Debt = 2.63% (Interest Expense 1.00m / Debt 38.0m)
Taxrate = 21.88% (7.00m / 32.0m)
NOPAT = 96.9m (EBIT 124.0m * (1 - 21.88%))
Current Ratio = 2.52 (Total Current Assets 1.10b / Total Current Liabilities 435.0m)
Debt / Equity = 0.03 (Debt 38.0m / totalStockholderEquity, last quarter 1.18b)
Debt / EBITDA = -1.37 (Net Debt -228.0m / EBITDA 166.0m)
Debt / FCF = -1.29 (Net Debt -228.0m / FCF TTM 177.0m)
Total Stockholder Equity = 1.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.85% (Net Income 95.0m / Total Assets 1.66b)
RoE = 8.26% (Net Income TTM 95.0m / Total Stockholder Equity 1.15b)
RoCE = 10.44% (EBIT 124.0m / Capital Employed (Equity 1.15b + L.T.Debt 38.0m))
RoIC = 8.42% (NOPAT 96.9m / Invested Capital 1.15b)
WACC = 9.87% (E(2.82b)/V(2.86b) * Re(9.98%) + D(38.0m)/V(2.86b) * Rd(2.63%) * (1-Tc(0.22)))
Discount Rate = 9.98% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -0.47%
[DCF Debug] Terminal Value 63.24% ; FCFF base≈215.4m ; Y1≈146.8m ; Y5≈72.2m
Fair Price DCF = 6.90 (EV 1.05b - Net Debt -228.0m = Equity 1.28b / Shares 185.7m; r=9.87% [WACC]; 5y FCF grow -37.23% → 2.90% )
EPS Correlation: -29.44 | EPS CAGR: -39.54% | SUE: -3.69 | # QB: 0
Revenue Correlation: 77.49 | Revenue CAGR: 10.77% | SUE: -0.25 | # QB: 0
EPS next Year (2026-12-31): EPS=1.05 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+25.8% | Growth Revenue=+92.4%